Loading...
XNAS
PODD
Market cap9.31bUSD
Oct 08, Last price  
134.47USD
1D
0.08%
1Q
-16.62%
Jan 2017
256.87%
IPO
770.36%
Name

Insulet Corp

Chart & performance

D1W1MN
XNAS:PODD chart
P/E
37.69
P/S
3.44
EPS
3.57
Div yield, %
—
Shrs. gr., 5y
1.74%
Rev. gr., 5y
24.53%
Revenues
2.71b
+30.73%
3,663,00013,372,00036,059,00066,032,00096,966,000152,255,000211,369,000247,084,000288,720,000263,893,000366,989,000463,768,000563,823,000738,200,000904,400,0001,098,800,0001,305,300,0001,697,100,0002,071,600,0002,708,100,000
Net income
247m
-40.93%
-35,950,000-53,539,000-92,791,000-79,541,000-61,159,000-57,170,000-51,867,000-44,974,000-51,500,000-73,520,000-28,879,000-26,831,0003,292,00011,600,0006,800,00016,800,0004,600,000206,300,000418,300,000247,100,000
CFO
569m
+32.30%
-31,820,000-50,372,000-82,611,000-49,323,000-35,625,000-25,452,000-29,059,0003,348,0008,920,000-12,552,00015,911,00041,300,00035,900,00098,400,00084,000,000-68,100,000119,000,000145,700,000430,300,000569,300,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Key people

President, Chief Executive Officer, Director · since 2025
Dan Manea
Chief Human Resources Officer, Senior Vice President · since 2020
Eric Benjamin
Executive Vice President, Chief Product and Customer Experience Officer · since 2023
Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance · since 2022
John Kapples
Senior Vice President, General Counsel · since 2021
Prem Singh
Senior Vice President - Global Operations · since 2023
Amit Guliani
Acting Chief Technology Officer, Group Vice President - Software Engineering · since 2025
Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller · since 2024
Manoj Raghunandanan
Chief Growth Officer · since 2025
Luciana Borio
Independent Director · since 2021
Independent Director · since 2020
Independent Director · since 2018
Robert Huffines
Independent Director · since 2025
Independent Director · since 2017
Independent Director · since 2024
Timothy Scannell
Independent Chairman of the Board · since 2019
Independent Director · since 2024
Independent Director · since 2022
IPO date
May 15, 2007
Employees
2,600
Domiciled in
US
Incorporated in
US
Legal address
C/O UNITED AGENT GROUP INC.
1521 CONCORD PIKE
SUITE 201
WILMINGTON, DE 19803
US
Headquarters
600 Technology Park Drive
Suite 200
Billerica, MA 01821
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT